- Global Pharma News & Resources

Pharmaceutical Isolator Market Global Sales are Expected to Experience Modest CAGR of 5.4% between 2023 to 2032 | insightSLICE

The global Pharmaceutical Isolator market size was estimated to be US$ 5.75 billion in 2021 and is expected grow at a CAGR of 5.4% between 2023 to 2032.

Pharmaceutical isolators are technically a contamination-free barrier system used in the pharmaceutical sector. To preserve the function and activity of biological compounds from any undesirable microbiological contamination an aseptic setting is required in the pharmaceutical industry.

Such contamination events can be produced by the employees and the environmental elements on the production team. Pharmaceutical isolator devices are able to seal the entire pharmaceutical production process from the operator and environment thus preventing any contamination.

Access the sample report:

Global Pharmaceutical Isolator Market Key Segments:

By Type

  • Aseptic isolators
  • Containment isolators
  • Bio isolators
  • Sampling and weighing isolators
  • Active pharmaceutical ingredient (API) manufacturing isolators
  • Others

By Product

  • Class III
  • ISO Class 5

By System

  • Closed system
  • Open system

By Pressure

  • Positive pressure
  • Negative pressure

By End-Use

  • Hospitals
  • Diagnostic laboratories
  • Academic and research institutes
  • Pharmaceutical and biotechnology companies
  • Contract research organization

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

A pharmaceutical isolator provides a sterile environment compared to traditional clean rooms. Pressure differences inside the isolator chamber prevent contamination from operator involvement, maintaining long-term sterility in compliance with pharmacological regulations governing the manufacture of sterile medical items.

Pharmaceutical isolators are required for cell therapy processing, the manufacture of advanced therapy medicinal products (ATMPs), and the weighing, packaging, and dispensing of injectable sterile products.

The key players of the Global Pharmaceutical Isolator Market are:

Amico Group of Companies, ArjoHuntleigh, Azbil, Comecer SPA, Fedegari Autoclavi SPA, Famed Zywiec SPA, Gelman Singapore, Getinge AB, Hill Room Holding, Hosokawa Micron Ltd., Iso Tech Design, Invacare Corporation, LAF Technologies, Malvestio SPA, Medline Industries Inc., Merivaara Corporation, Midmark Corporation, MBraun, NuAire Inc., Paramount Bed Co., Ltd., Span America Medical System Inc., Skan AG, Robert Bosch GmbH, Schematic Engineering Industries, VanRx Pharmasystems Inc and others are some of the biggest companies involved in the global pharmaceutical isolator market.

Read more about the report inclusions:

Driving factors for the growth of Global Pharmaceutical Isolator Market

A large proportion of pharmaceutical isolators are specifically made for production or manufacturing companies. Pharmaceutical isolators offer low running costs, which is another major driver of market expansion. Isolators from reliable suppliers may be obtained for a small portion of the cost of normal clean rooms by pharmaceutical corporations.

The pharmaceutical isolator product reduces contamination which a clean room with an operator may have creating a bio-decontaminated atmosphere in which only the medicine and manufacturing materials interact.

The biotechnology and pharmaceutical category are estimated to have the greatest market share and to have the highest growth rate throughout the projection period. However, the demand for pharmaceutical isolators in containment solutions for food, cosmetics, and detergent industries is also expected to enable their growth.

Key developments such as better mobility, improved consistency with active pharmaceutical ingredients (APIs), and a large sterility assurance facilitate isolator demand for pharmaceutical applications. These variables have enabled new sales and contributed to the growth of the global pharmaceutical isolators market.

The increased usage of hazardous substances, rising penal charges of noncompliance, and rise in demand from new research and production facilities are major drivers pushing the pharmaceutical isolators market.

Improved strategic cooperation and a stringent product approval procedure are driving the pharmaceutical isolator market expansion. The ongoing expansion of the pharmaceutical business in both developed and emerging nations is boosting the usage of pharmaceutical isolation systems.

The pharmaceutical isolator industry will keep growing throughout the projected period by responding to pharma-specific industry requirements and upgrading its isolator design and technologies.

Related reports:

Global Biobanks Market:

Global Airway Management Devices Market:

Challenges of Global Pharmaceutical Isolator Market

Drug regulatory authorities are also promoting/advocating the use of breakthroughs like pharmaceutical isolators in manufacturing of the pharmaceutical products. The FDA, for example, discusses isolators on 55 occasions in its most recent guideline for production in an aseptic environment.

Furthermore, the FDA recognizes the unanticipated removal of operators in important sections of pharmaceutical manufacturing, which is projected to accelerate the implementation of pharmaceutical isolators in the future years. Such measures will enable quicker adoption and purchase of pharmaceutical isolators to increase its market share.

COVID-19 impact on Pharmaceutical Isolator market

The global COVID-19 pandemic has provided pharmaceutical and biomedical companies with several chances to expand their R&D expenditures in order to create innovative chemicals, compounds, and vaccines for controlling the spread and treating critically ill patients. Because of the tremendous increase in pharmaceutical output, all major companies throughout the world have raised their demand for pharmaceutical isolators.

As the number of clinical trials grows, so does the demand for pharmaceutical companies to acquire and operate a significant number of pharmaceutical isolators. As a result, it is reasonable to state that the Covid-19 epidemic has unleashed a rapid expansion in the pharmaceutical isolator industry in the next few years.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 07-Nov-2022